Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aurinia Pharmaceuticals Inc

AUPH
Current price
5.65 USD +0.39 USD (+7.33%)
Last closed 5.35 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 799 476 288 USD
Yield for 12 month -43.10 %
1Y
3Y
5Y
10Y
15Y
AUPH
21.11.2021 - 28.11.2021

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada. Address: 118 Avenue , 14315, Edmonton, AB, Canada, T5L 4S6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.86 USD

P/E ratio

Dividend Yield

Current Year

+175 513 000 USD

Last Year

+134 030 000 USD

Current Quarter

+50 303 000 USD

Last Quarter

+45 095 000 USD

Current Year

+161 365 000 USD

Last Year

+128 366 000 USD

Current Quarter

+42 551 000 USD

Last Quarter

+39 700 000 USD

Key Figures AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -47 000 000 USD
Operating Margin TTM -13.06 %
PE Ratio
Return On Assets TTM -8.1 %
PEG Ratio
Return On Equity TTM -16.69 %
Wall Street Target Price 10.86 USD
Revenue TTM 191 407 008 USD
Book Value 2.5 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 46.2 %
Dividend Yield
Gross Profit TTM 83 378 000 USD
Earnings per share -0.44 USD
Diluted Eps TTM -0.44 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -32.69 %

Dividend Analytics AUPH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 23.10.2013
Dividend Date

Stock Valuation AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 128.2051
Enterprise Value Revenue 2.7614
Price Sales TTM 4.2023
Enterprise Value EBITDA -7.6874
Price Book MRQ 1.9514

Financials AUPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AUPH

For 52 weeks

4.71 USD 12.43 USD
50 Day MA 5.2 USD
Shares Short Prior Month 11 533 429
200 Day MA 7.1 USD
Short Ratio 8.54
Shares Short 9 205 494
Short Percent 8.11 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

441.58 USD Microsoft Corporation +0.8 (+0.18%)
Detailed analytics

ETF funds


S

SX7EEX

13.85 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.35 (-2.26%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics